Ttango: Operational Performance of a Molecular Based Chlamydia and Gonorrhoea Point-of-Care Testing in Remote Australian Aboriginal Communities
Belinda Hengel, MPH1, Steven Badman, MPH, PhD Candidate2, Louise Causer, MBBS MScPh DTM&H3, Lisa Natoli, MPH4, Annie Tangey, MPH5, James Ward, BA6, Sepehr Tabrizi, MS PhD FFSc(RCPA) FASM7, David Whiley, PhD8, Basil Donovan, MBBS DipVen PhD FAChSHM2, Christopher “Kit” Fairley, MBBS PhD FAChSHM9, David Wilson, PhD3, David Regan, PhD3, Handan Wand, PhD3, Mark Shephard, PhD OAM10, David Anderson, PhD11, John Kaldor, PhD3 and Rebecca Guy, PhD3, 1Kirby Institute, University of New South Wales, Coogee, Australia, 2Kirby Institute, University of New South Wales, Coogee, Sydney, Australia, 3Kirby Institute, University of New South Wales, Sydney, Australia, 4Office for Business Development, Innovation and Research, Burnet Institute, on behalf of the TTANGO Investigator Group, Melbourne, Victoria, 3001, Australia, 5Ngaanyatjarra Health, 6Baker IDI Alice Springs, 7The Royal Womens Hospital, Parkville, Australia, 8Royal Childrens Hospital/The University of Queensland, Herston, Brisbane, Australia, 9University of Melbourne, 10Flinders University, 11Burnet Institute